Tenax Therapeutics (TENX) Net Income (2016)
Historic Net Income for Tenax Therapeutics (TENX) over the last 6 years, with Q4 2016 value amounting to -$34.3 million.
- Tenax Therapeutics' Net Income fell 18307.41% to -$34.3 million in Q4 2016 from the same period last year, while for Sep 2017 it was -$34.3 million, marking a year-over-year decrease of 6104.01%. This contributed to the annual value of -$17.6 million for FY2024, which is 12643.43% down from last year.
- According to the latest figures from Q4 2016, Tenax Therapeutics' Net Income is -$34.3 million, which was down 18307.41% from -$4.5 million recorded in Q3 2016.
- In the past 5 years, Tenax Therapeutics' Net Income registered a high of $108.6 million during Q2 2012, and its lowest value of -$118.0 million during Q2 2013.
- Moreover, its 4-year median value for Net Income was -$4.6 million (2016), whereas its average is -$8.0 million.
- Data for Tenax Therapeutics' Net Income shows a peak YoY increase of 371057.81% (in 2012) and a maximum YoY decrease of 35790.41% (in 2012) over the last 5 years.
- Quarter analysis of 4 years shows Tenax Therapeutics' Net Income stood at -$1.6 million in 2012, then plummeted by 7512.64% to -$118.0 million in 2013, then skyrocketed by 89.74% to -$12.1 million in 2015, then tumbled by 183.07% to -$34.3 million in 2016.
- Its Net Income stands at -$34.3 million for Q4 2016, versus -$4.5 million for Q3 2016 and -$4.7 million for Q2 2016.